For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
2001
|
2000
|
|
Assets |
|
|
Current Assets |
85,068
|
71,284
|
Investments |
353,827
|
397,622
|
Assets Whose Use Is Limited |
1,351
|
1,273
|
Property, Plant, and Equipment, net |
213,288
|
215,765
|
Contributions Receivable, less current portion |
15,427
|
16,856
|
Other Assets |
5,958
|
4,758
|
Total Assets |
$674,919
|
$707,558
|
|
Liabilities and Net Assets |
|
|
Current Liabilities |
94,863
|
75,746
|
Long-Term Debt and Other Liabilities |
152,151
|
150,867
|
Net Assets |
|
|
Unrestricted |
221,532
|
26,854
|
Temporarily Restricted |
121,053
|
131,333
|
Permanently Restricted |
85,320
|
8,758
|
Subtotal Net Assets |
427,905
|
480,945
|
Total Liabilities and Net Assets |
$674,919
|
$707,558
|
|
Summary Statistical Information |
|
|
(Unless otherwise noted, includes adult and pediatric patients) |
2001
|
2000
|
Number of Licensed Beds (as of year end) |
27 |
27 |
Adult Inpatient Discharges |
969
|
932
|
Infusion Visits |
48,030
|
43,722
|
Outpatient MD Visits |
79,918
|
74,811
|
Clinical Trials (via Dana-Farber/Harvard Cancer Center) |
515
|
397
|
|
